TRIMEBUTINE BIOGARAN 100 mg, tablet 30 tablets, CIP 3400930128169
Active ingredients: Trimebutine maleate
Commercialized according to BDPMDispensing in France: Prescription only
Tablet30 tablets, CIP 3400930128169orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TRIMEBUTINE BIOGARAN 100 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- flacon(s) polyéthylène haute densité (PEHD) de 30 comprimé(s) avec fermeture de sécurité enfant
- Marketing authorisation holder
- BIOGARAN
- Reimbursement according to BDPM
- 15%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 10 Nov 2025
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60955940CIP73012816CIP133400930128169Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MALÉATE DE TRIMÉBUTINEcomprimé | 100 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.